Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study

This publication has 24 references indexed in Scilit:

• Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor
  Journal of Clinical Oncology, 2013
• Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
  New England Journal of Medicine, 2012
• Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
  JAMA, 2011
• Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
  New England Journal of Medicine, 2011
• Characteristics of the coexistence of melanoma and renal cell carcinoma
  Cancer, 2010
• Risk of second primary malignancies following cutaneous melanoma diagnosis: A population-based study
  Journal of the American Academy of Dermatology, 2010
• Increased Risk of Second Primary Cancers After a Diagnosis of Melanoma
  Archives of Dermatology, 2010
• Methods for stratification of person-time and events – a prerequisite for Poisson regression and SIR estimation
  Epidemiologic Perspectives & Innovations, 2008
• Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy
  Cancer Epidemiology, Biomarkers & Prevention, 2007
• Second cancers after radiotherapy: any evidence for radiation-induced genomic instability?
  Oncogene, 2003